+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Edema Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 115 Pages
  • December 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5916627
Description Jump to:
The 'edema clinical trials market' is undergoing significant advancements and is expected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2031, fueled by evolving research methodologies and a growing focus on diverse participant demographics. As we transition from 2022, marked by substantial revenues, to the forecast period of 2023 to 2031, the Edema Clinical Trials market is poised for continued expansion. The ongoing innovative strategies employed in clinical trials are expected to shape the landscape of edema treatment, addressing the complexities of diverse patient populations and paving the way for more effective and patient-centric interventions.

Advancements in Therapeutic Approaches

The foremost driver in the Edema Clinical Trials market is the continuous evolution of therapeutic approaches. As evidenced by the emergence of novel drug candidates and interventions, ongoing clinical trials are exploring innovative mechanisms to address edema more effectively. Investigational treatments targeting specific pathways, such as vascular permeability and lymphatic function, have demonstrated promising results in early-phase trials. These advancements reflect a concerted effort to enhance treatment efficacy and reduce adverse effects, paving the way for more targeted and personalized interventions.

Increased Emphasis on Pediatric Research

A crucial driver shaping the landscape of edema clinical trials is the increased emphasis on pediatric research. Recognizing the unique challenges and distinct physiological responses in pediatric populations, recent trials have focused on developing evidence-based interventions specifically tailored to children. This shift is evident in the inclusion of pediatric cohorts in multi-phase trials, ensuring the safety and efficacy of edema treatments for this demographic. By addressing the unmet medical needs of pediatric patients, these trials contribute to a more comprehensive understanding of edema management across diverse age groups.

Growing Integration of Digital Technologies

Another key driver propelling the Edema Clinical Trials market is the growing integration of digital technologies. From electronic data capture systems to wearable devices monitoring edema-related parameters, clinical trials are leveraging digital innovations to enhance data accuracy, streamline patient monitoring, and improve overall trial efficiency. Real-time data collection and analysis enable researchers to make informed decisions, accelerating the pace of clinical trials and contributing to the timely development of effective edema treatments.

Challenges in Patient Recruitment and Retention

A significant restraint in the Edema Clinical Trials market is the persistent challenge of patient recruitment and retention. Despite the advancements in therapeutic approaches and digital technologies, enrolling a diverse and representative participant pool remains a complex task. Evidence supporting this restraint includes instances of prolonged trial timelines and increased costs due to difficulties in recruiting a sufficient number of eligible participants. Additionally, the high attrition rates observed in some trials underscore the need for innovative strategies to enhance patient engagement and retention throughout the trial duration.

By Phase: Phase III trials Dominates the Market

In 2022, the Edema Clinical Trials market experienced substantial revenue across different phases, with Phase III trials generating the highest revenue. However, Phase IV trials demonstrated the highest CAGR during the forecast period from 2023 to 2031, indicating a shift towards post-marketing research and continued exploration of long-term treatment outcomes. This dynamic segmentation underscores the evolving nature of clinical research in edema, emphasizing both advanced stages and post-marketing surveillance.

By Participant: The Adults Segment Dominates the Market

Market segmentation by participants in 2022 showcased robust revenue streams from adults, reflecting the predominant focus on this demographic in clinical trials. However, Pediatrics demonstrated the highest CAGR during the forecast period, highlighting a growing recognition of the importance of pediatric research in addressing edema in younger populations. Simultaneously, Geriatrics maintained substantial revenue, illustrating a comprehensive approach that considers the unique characteristics of elderly patients in clinical trial design.

North America Remains the Global Leader

Geographically, the Edema Clinical Trials market exhibited diverse trends in 2022, with North America leading in revenue generation. However, the Asia-Pacific region showcased the highest CAGR, reflecting a surge in clinical trial activities and increasing investment in research infrastructure. Balancing revenue and CAGR, these geographic trends underscore the global nature of edema clinical trials, with diverse regions contributing uniquely to research advancements.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Pfizer Inc., Novartis AG, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche Ltd., Bayer, Genentech, Inc, Biogen, Inflammasome Therapeutics, Sanofi S.A. and OcuTerra Therapeutics are driving innovation and shaping the future of edema clinical trials. These key players reported substantial revenues in 2022, expecting continued growth from 2023 to 2031. Their strategic focus on developing advanced therapeutic approaches, emphasizing pediatric research, and leveraging digital technologies positions them as influential entities in the edema clinical trials landscape. As the market evolves, these players are anticipated to play a pivotal role in advancing clinical research, ultimately contributing to the development of more effective treatments for edema.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. Key data points that enable the estimation of the Edema Clinical Trials market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value
  • Geographical revenues generated by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Edema Clinical Trials market and their expected impact during the forecast period
The market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

  • Phase
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • Participant
  • Pediatrics
  • Adults
  • Geriatrics
  • Study Design
  • Interventional Trials
  • Observational Trials
  • Expanded Access Trials
  • Type
  • Systemic Edema
  • Localized Edema

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Edema Clinical Trials market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Edema Clinical Trials market?
  • Which is the largest regional market for Edema Clinical Trials market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Edema Clinical Trials market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Edema Clinical Trials market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Edema Clinical Trials Market
2.2. Global Edema Clinical Trials Market, By Phase, 2022 (US$ Million)
2.3. Global Edema Clinical Trials Market, By Participant, 2022 (US$ Million)
2.4. Global Edema Clinical Trials Market, By Study Design, 2022 (US$ Million)
2.5. Global Edema Clinical Trials Market, By Type, 2022 (US$ Million)
2.6. Global Edema Clinical Trials Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022
3. Edema Clinical Trials Market: Competitive Analysis
3.1. Market Positioning of Key Edema Clinical Trials Market Vendors
3.2. Strategies Adopted by Edema Clinical Trials Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Edema Clinical Trials Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Edema Clinical Trials Market Value, 2021-2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Phase I
5.3.2. Phase II
5.3.3. Phase III
5.3.4. Phase IV
6. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Pediatrics
6.3.2. Adults
6.3.3. Geriatrics
7. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Interventional Trials
7.3.2. Observational Trials
7.3.3. Expanded Access Trials
8. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
8.3.1. Systemic Edema
8.3.2. Localized Edema
9. North America Edema Clinical Trials Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
9.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
9.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
9.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
9.6. Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
9.6.1. North America
9.6.1.1. U.S.
9.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
9.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
9.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
9.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
9.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
9.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
9.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
9.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
9.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
9.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10. UK and European Union Edema Clinical Trials Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6. Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
10.6.1. UK and European Union
10.6.1.1. UK
10.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.1.5. France
10.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
10.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
10.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
10.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11. Asia Pacific Edema Clinical Trials Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6. Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
11.6.1. Asia Pacific
11.6.1.1. China
11.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.1.3. India
11.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
11.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
11.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
11.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
12. Latin America Edema Clinical Trials Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
12.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
12.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
12.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
12.6. Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
12.6.1. Latin America
12.6.1.1. Brazil
12.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
12.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
12.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
12.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
12.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
12.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
12.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
12.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
12.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
12.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
13. Middle East and Africa Edema Clinical Trials Market, 2021-2031, USD (Million)
13.1. Market Overview
13.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
13.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
13.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
13.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
13.6. Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
13.6.1. Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
13.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
13.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
13.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
13.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
13.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
13.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
13.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
13.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
13.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
14. Company Profile
14.1. Pfizer Inc.
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Novartis AG
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. Johnson & Johnson
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Otsuka Holdings
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. F. Hoffmann-La Roche Ltd.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Bayer
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. Genentech, Inc
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. Biogen
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Inflammasome Therapeutics
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Sanofi S.A.
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. OcuTerra Therapeutics
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Other Notable Players
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
List of Figures
Figure 1 Global Edema Clinical Trials Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Edema Clinical Trials Market: Quality Assurance
Figure 5 Global Edema Clinical Trials Market, By Phase, 2022
Figure 6 Global Edema Clinical Trials Market, By Participant, 2022
Figure 7 Global Edema Clinical Trials Market, By Study Design, 2022
Figure 8 Global Edema Clinical Trials Market, By Type, 2022
Figure 9 Global Edema Clinical Trials Market, By Geography, 2022
Figure 10 Market Geographical Opportunity Matrix - Global Edema Clinical Trials Market, 2022
Figure 11 Market Positioning of Key Edema Clinical Trials Market Players, 2022
Figure 12 Global Edema Clinical Trials Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure 13 Global Edema Clinical Trials Market, By Phase, 2022 Vs 2031, %
Figure 14 Global Edema Clinical Trials Market, By Participant, 2022 Vs 2031, %
Figure 15 Global Edema Clinical Trials Market, By Study Design, 2022 Vs 2031, %
Figure 16 Global Edema Clinical Trials Market, By Type, 2022 Vs 2031, %
Figure 17 U.S. Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 18 Canada Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 19 Rest of North America Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 20 UK Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 21 Germany Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 22 Spain Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 23 Italy Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 24 France Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 25 Rest of Europe Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 26 China Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 27 Japan Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 28 India Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 29 Australia Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 30 South Korea Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 31 Rest of Asia Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 32 Brazil Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 33 Mexico Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 34 Rest of Latin America Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 35 GCC Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 36 Africa Edema Clinical Trials Market (US$ Million), 2021-2031
Figure 37 Rest of Middle East and Africa Edema Clinical Trials Market (US$ Million), 2021-2031
List of Tables
Table 1 Global Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 2 Global Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 3 Global Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 4 Global Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 5 North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 6 North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 7 North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 8 North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 9 U.S. Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 10 U.S. Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 11 U.S. Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 12 U.S. Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 13 Canada Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 14 Canada Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 15 Canada Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 16 Canada Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 17 Rest of North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 18 Rest of North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 19 Rest of North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 20 Rest of North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 21 UK and European Union Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 22 UK and European Union Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 23 UK and European Union Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 24 UK and European Union Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 25 UK Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 26 UK Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 27 UK Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 28 UK Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 29 Germany Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 30 Germany Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 31 Germany Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 32 Germany Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 33 Spain Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 34 Spain Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 35 Spain Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 36 Spain Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 37 Italy Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 38 Italy Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 39 Italy Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 40 Italy Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 41 France Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 42 France Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 43 France Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 44 France Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 45 Rest of Europe Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 46 Rest of Europe Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 47 Rest of Europe Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 48 Rest of Europe Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 49 Asia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 50 Asia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 51 Asia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 52 Asia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 53 China Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 54 China Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 55 China Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 56 China Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 57 Japan Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 58 Japan Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 59 Japan Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 60 Japan Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 61 India Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 62 India Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 63 India Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 64 India Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 65 Australia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 66 Australia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 67 Australia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 68 Australia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 69 South Korea Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 70 South Korea Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 71 South Korea Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 72 South Korea Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 73 Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 74 Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 75 Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 76 Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 77 Brazil Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 78 Brazil Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 79 Brazil Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 80 Brazil Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 81 Mexico Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 82 Mexico Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 83 Mexico Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 84 Mexico Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 85 Rest of Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 86 Rest of Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 87 Rest of Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 88 Rest of Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 89 Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 90 Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 91 Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 92 Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 93 GCC Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 94 GCC Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 95 GCC Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 96 GCC Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 97 Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 98 Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 99 Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 100 Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
Table 101 Rest of Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
Table 102 Rest of Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
Table 103 Rest of Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
Table 104 Rest of Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)

Companies Mentioned

  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • Otsuka Holdings
  • F. Hoffmann-La Roche Ltd.
  • Bayer
  • Genentech, Inc
  • Biogen
  • Inflammasome Therapeutics
  • Sanofi S.A.
  • OcuTerra Therapeutics

Related Topics

Related Reports

Edema Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Edema Clinical Trials Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 181 Pages
  • Global
From
Retinal Edema - Pipeline Insight, 2024 - Product Image

Retinal Edema - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Pulmonary Edema Therapeutics - Global Strategic Business Report - Product Image

Pulmonary Edema Therapeutics - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Amiloride hydrochloride Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Amiloride hydrochloride Market by Product Type, Application, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Lymphoedema - Pipeline Insight, 2024 - Product Image

Lymphoedema - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From

About the Edema Drug Market

The Edema Drug market is a subset of the Cardiovascular Drugs market, focusing on drugs used to treat edema, a condition characterized by swelling due to fluid accumulation in the body's tissues. These drugs are used to reduce swelling and improve symptoms such as pain, discomfort, and difficulty breathing. Commonly used edema drugs include diuretics, which reduce the amount of fluid in the body, and vasodilators, which relax the blood vessels and reduce swelling. Other drugs used to treat edema include ACE inhibitors, angiotensin receptor blockers, and calcium channel blockers. The Edema Drug market is highly competitive, with many companies offering a variety of drugs to treat edema. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.